CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 61 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Ketamine 1mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02514122
NCT02514122Phase 3Completed
CompareCT.gov

Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda: a Randomized Control Trial

University of Saskatchewan·interventional·Posted Aug 3, 2015·Updated Nov 9, 2018

In Brief

A Phase 3 clinical trial evaluating Ketamine and Saline for Post Operative Pain and Pain. Completed, enrolled 61 participants across 1 site.

Detailed Summary

A randomized double blind control trial to investigate the safety and efficacy of subcutaneous ketamine for control of post operative pain in low resource settings.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Operative Pain, Pain
CountriesRwanda
CollaboratorsNational University, Rwanda

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 3, 2015
Enrollment StartJun 1, 2015
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.9 years ago

Interventions

Ketaminedrug

Patients will receive a subcutaneous injection of ketamine (at a dose of 1mg/kg) immediately following surgery, the evening after surgery, and every 12 hours thereafter for a total of 5 injections.

Salinedrug

Patients will receive a subcutaneous injection of saline (at a dose of 0.02cc/kg) immediately following surgery, the evening after surgery, and every 12 hours thereafter for a total of 5 injections.